4,047 results match your criteria Peroxisomal Disorders


Peroxisomal dysfunction in neurodegenerative diseases.

Arch Pharm Res 2019 Feb 9. Epub 2019 Feb 9.

School of Life Sciences, Kyungpook National University, 80 Daehakro Bukgu, Daegu, 41566, Republic of Korea.

Peroxisomes and their (patho-)physiological importance in heath and disease have attracted increasing interest during last few decades. Together with mitochondria, peroxisomes comprise key metabolic platforms for oxidation of various fatty acids and redox regulation. In addition, peroxisomes contribute to bile acid, cholesterol, and plasmalogen biosynthesis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01131-2DOI Listing
February 2019

Leukodystrophy caused by plasmalogen deficiency rescued by glyceryl 1-myristyl ether treatment.

Brain Pathol 2019 Jan 22. Epub 2019 Jan 22.

Neurolipid Biology, Instituto de Investigação e Inovação em Saúde - i3S, Instituto de Biologia Molecular e Celular - IBMC e Universidade do Porto, Porto, Portugal.

Plasmalogens are the most abundant form of ether-phospholipids in myelin and their deficiency causes Rhizomelic Chondrodysplasia Punctata (RCDP), a severe developmental disorder. Using the Gnpat knockout (KO) mouse as a model of RCDP, we determined the consequences of a plasmalogen deficiency during myelination and myelin homeostasis in the central nervous system (CNS). We unraveled that the lack of plasmalogens causes a generalized hypomyelination in several CNS regions including optic nerve, corpus callosum and spinal cord. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bpa.12710DOI Listing
January 2019
1 Read

Targeted gene approach with biochemical assay confirms ABCD1 mutation of X-linked adrenoleukodystrophy in a 62-year-old man with gait imbalance.

Neuromuscul Disord 2018 Nov 22. Epub 2018 Nov 22.

Department of Neurology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.

X-linked adrenoleukodystrophy is a peroxisomal disorder caused by a mutation in ABCD1 gene. The three main phenotypes of X-linked adrenoleukodystrophy include cerebral adrenoleukodystrophy, adrenomyeloneuropathy, and isolated primary adrenal insufficiency. More than 750 non-recurrent mutations exist throughout the coding region of the ABCD1 gene. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nmd.2018.11.007DOI Listing
November 2018
4 Reads

[Peroxisomal disorders].

Postepy Biochem 2018 12;64(4):359-367

Zakład Biochemii i Medycyny Doświadczalnej, Instytut "Pomnik-Centrum Zdrowia Dziecka".

Peroxisomes are multifunctional microorganelles that play a key role in numerous biochemical processes adapting dynamically to the current physiological requirements of the cell. The disturbance of the peroxisome structure due to mutations in different PEX and non-PEX genes coding functional peroxisomal proteins is the pathogenic basis of the peroxisomal disorders. The β-oxidation process of very long-chain fatty acids (VLCFA) is a unique metabolic pathway located exclusively in the peroxisome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18388/pb.2018_150DOI Listing
December 2018
2 Reads

Ataxia with novel compound heterozygous PEX10 mutations and a literature review of PEX10-related peroxisome biogenesis disorders.

Clin Neurol Neurosurg 2019 Feb 7;177:92-96. Epub 2019 Jan 7.

Department of Neurology and Institute of Neurology, Rui Jin Hospital & Rui Jin Hospital North, Shanghai Jiao Tong University School of Medicine, 200025, China. Electronic address:

Objectives: To describe the clinical and genetic features of a Chinese peroxisome biogenesis disorder 6B patient with PEX10 mutations and review PEX10-related peroxisomal disorders.

Patients And Methods: The proband is a 7-year-old boy with mild mental retardation and gait instability, intention tremor and nystagmus. An extensive clinical and laboratory evaluation including molecular genetic studies was performed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2019.01.004DOI Listing
February 2019
2 Reads
1.248 Impact Factor

Differential distribution of peroxisomal proteins points to specific roles of peroxisomes in the murine retina.

Mol Cell Biochem 2019 Jan 2. Epub 2019 Jan 2.

Department of Pharmaceutical and Pharmacological Sciences, Cell Metabolism, KU Leuven -University of Leuven, 3000, Leuven, Belgium.

The retinal pathology in peroxisomal disorders suggests that peroxisomes are important to maintain retinal homeostasis and function. These ubiquitous cell organelles are mainly involved in lipid metabolism, which comprises α- and β-oxidation and ether lipid synthesis. Although peroxisomes were extensively studied in liver, their role in the retina still remains to be elucidated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-018-3489-3DOI Listing
January 2019
1 Read

Clinical and Biochemical Features in a Patient With Gene Alteration.

Front Genet 2018 7;9:625. Epub 2018 Dec 7.

Unit of Child Neurology and Psychiatry, Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.

Mitochondrial Fission Factor (MFF) is part of a protein complex that promotes mitochondria and peroxisome fission. Hitherto, only 5 patients have been reported harboring mutations in , all of them with the clinical features of a very early onset Leigh-like encephalopathy. We report on an 11-year-old boy with epileptic encephalopathy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2018.00625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292958PMC
December 2018
1 Read

The many faces of peroxisomal disorders: Lessons from a large Arab cohort.

Clin Genet 2019 Feb 18;95(2):310-319. Epub 2018 Dec 18.

Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Defects in the peroxisomes biogenesis and/or function result in peroxisomal disorders. In this study, we describe the largest Arab cohort to date (72 families) of clinically, biochemically and molecularly characterized patients with peroxisomal disorders. At the molecular level, we identified 43 disease-causing variants, half of which are novel. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cge.13481
Publisher Site
http://dx.doi.org/10.1111/cge.13481DOI Listing
February 2019
5 Reads
3.931 Impact Factor

Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.

Medicine (Baltimore) 2018 Dec;97(49):e13353

Department of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, Poland.

Rationale: X-linked adrenoleukodystrophy (X-ALD) is a rare disorder caused by mutations in the ABCD1 gene, coding for peroxisomal membrane transporter adrenoleukodystrophy (ALD) protein. The disease is characterized by accumulation of very long chain fatty acids (VLCFAs) in tissues. Adult adrenomyeloneuropathy (AMN) and the cerebral inflammatory form of ALD are the main phenotypes presenting various symptoms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000013353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310492PMC
December 2018
1 Read

Peroxisome biogenesis deficiency attenuates the BDNF-TrkB pathway-mediated development of the cerebellum.

Life Sci Alliance 2018 Dec 3;1(6):e201800062. Epub 2018 Dec 3.

Division of Organelle Homeostasis, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Peroxisome biogenesis disorders (PBDs) manifest as neurological deficits in the central nervous system, including neuronal migration defects and abnormal cerebellum development. However, the mechanisms underlying pathogenesis remain enigmatic. Here, to investigate how peroxisome deficiency causes neurological defects of PBDs, we established a new PBD model mouse defective in peroxisome assembly factor Pex14p, termed mouse. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.26508/lsa.201800062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277683PMC
December 2018
10 Reads

Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder.

Case Rep Gastroenterol 2018 Sep-Dec;12(3):661-670. Epub 2018 Nov 21.

Division of Pediatric Gastroenterology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

Zellweger spectrum disorders (ZSDs) are a subgroup of peroxisomal biogenesis disorders with a generalized defect in peroxisome function. Liver disease in ZSDs has been associated with the lack of peroxisomal β-oxidation of C-bile acid intermediates to form primary C-bile acids, which prevents normal physiologic feedback and leads to accumulation of hepatotoxic bile acid intermediates. Primary bile acid therapy, oral cholic acid (CA), as adjunctive treatment for ZSDs, restores physiologic feedback inhibition on bile acid synthesis and inhibits formation of hepatotoxic bile acid intermediates. Read More

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/494555
Publisher Site
http://dx.doi.org/10.1159/000494555DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276768PMC
November 2018
19 Reads

Peroxisomes and Cellular Oxidant/Antioxidant Balance: Protein Redox Modifications and Impact on Inter-organelle Communication.

Subcell Biochem 2018 ;89:435-461

Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Box 601, 3000, Louvain, Belgium.

Disturbances in cellular redox balance have been associated with pro-aging mechanisms and increased risk for various chronic disease states. Multiple lines of evidence indicate that peroxisomes are central players in cellular redox metabolism. Nevertheless, the potential role of this organelle as intracellular redox signaling platform has been largely overlooked for a long time. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-981-13-2233-4_19
Publisher Site
http://dx.doi.org/10.1007/978-981-13-2233-4_19DOI Listing
January 2018
7 Reads

Defining the Mammalian Peroxisomal Proteome.

Subcell Biochem 2018 ;89:47-66

Faculty of Biology and BIOSS Centre for Biological Signaling Studies, Biochemistry and Functional Proteomics, Institute for Biology II, University of Freiburg, 79104, Freiburg, Germany.

The current view on peroxisomes has changed dramatically from being human cell oddities to vital organelles that host several key metabolic pathways. To fulfil over 50 different enzymatic functions, human peroxisomes host either unique peroxisomal proteins or dual-localized proteins. The identification and characterization of the complete peroxisomal proteome in humans is important for diagnosis and treatment of patients with peroxisomal disorders as well as for uncovering novel peroxisomal functions and regulatory modules. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-981-13-2233-4_2
Publisher Site
http://dx.doi.org/10.1007/978-981-13-2233-4_2DOI Listing
January 2018
1 Read

Isoform-specific domain organization determines conformation and function of the peroxisomal biogenesis factor PEX26.

Biochim Biophys Acta Mol Cell Res 2019 Mar 23;1866(3):518-531. Epub 2018 Oct 23.

University Children's Research@Kinder-UKE, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Children's Hospital, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Electronic address:

Peroxisomal biogenesis factor PEX26 is a membrane anchor for the multi-subunit PEX1-PEX6 protein complex that controls ubiquitination and dislocation of PEX5 cargo receptors for peroxisomal matrix protein import. PEX26 associates with the peroxisomal translocation pore via PEX14 and a splice variant (PEX26Δex5) of unknown function has been reported. Here, we demonstrate PEX26 homooligomerization mediated by two heptad repeat domains adjacent to the transmembrane domain. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01674889183047
Publisher Site
http://dx.doi.org/10.1016/j.bbamcr.2018.10.013DOI Listing
March 2019
11 Reads

Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids.

J Cell Biochem 2019 Mar 26;120(3):3243-3258. Epub 2018 Oct 26.

Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

Zellweger spectrum disorder (ZSD) results from biallelic mutations in PEX genes required for peroxisome biogenesis. PEX1-G843D is a common hypomorphic allele in the patient population that is associated with milder disease. In prior work using a PEX1-G843D/null patient fibroblast line expressing a green fluorescent protein (GFP) reporter with a peroxisome-targeting signal (GFP-PTS1), we demonstrated that treatments with the chemical chaperone betaine and flavonoid acacetin diacetate recovered peroxisome functions. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcb.27591
Publisher Site
http://dx.doi.org/10.1002/jcb.27591DOI Listing
March 2019
18 Reads

Neonatal punctate calcifications associated with maternal mixed connective tissue disorder (MCTD).

BMJ Case Rep 2018 Oct 12;2018. Epub 2018 Oct 12.

Neonatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Chondrodysplasia punctate (CDP) is a rare group of disorders with both genetic and non-genetic underlying aetiologies. The genetic causes associated with CDP include peroxisomal disorders, type two mucolipidosis, type 3 mucopolysaccharidosis, GM1 gangliosidosis and chromosomal disorders. Peroxisomal disorders include deficiency of dihydroxyacetone phosphate acyltransferase, encoded by GNPAT, deficiency of the peroxisomal enzyme alkyl-dihydroxyacetone phosphate synthase, encoded by AGPS and Zellweger syndrome. Read More

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2017-22337
Publisher Site
http://dx.doi.org/10.1136/bcr-2017-223373DOI Listing
October 2018
12 Reads

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.

Orphanet J Rare Dis 2018 Oct 11;13(1):179. Epub 2018 Oct 11.

School of Health and Related Research, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.

Background: A decision tree model was built to estimate the economic impact of introducing screening for X-linked adrenoleukodystrophy (X-ALD) into an existing tandem mass spectrometry based newborn screening programme. The model was based upon the UK National Health Service (NHS) Newborn Blood Spot Screening Programme and a public service perspective was used with a lifetime horizon. The model structure and parameterisation were based upon literature reviews and expert clinical judgment. Read More

View Article

Download full-text PDF

Source
https://ojrd.biomedcentral.com/articles/10.1186/s13023-018-0
Publisher Site
http://dx.doi.org/10.1186/s13023-018-0921-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182830PMC
October 2018
4 Reads

Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.

J Biochem 2019 Jan;165(1):67-73

Biochemical Genetics, Sandor Life Sciences Pvt Ltd, Banjara Hills, Road No: 3, Hyderabad, India.

We have established diagnostic thresholds of very long-chain fatty acids (VLCFA) for the differential diagnosis of peroxisomal disorders using the machine learning tools. The plasma samples of 131 controls and 90 cases were tested for VLCFA using gas chromatography-mass spectrometry following stable isotope dilution. These data were used to construct association rules and for recursive partitioning. Read More

View Article

Download full-text PDF

Source
http://fdslive.oup.com/www.oup.com/pdf/production_in_progres
Publisher Site
http://dx.doi.org/10.1093/jb/mvy085DOI Listing
January 2019
5 Reads

[The importance of semiology and biochemistry in the diagnostic management of a peroxisomal biogenesis disorder].

Rev Neurol 2018 Oct;67(8):298-302

Instituto de Ortopedia Infantil Roosevelt, Bogota DC, Colombia.

Introduction: Peroxisomal biogenesis disorders are due to mutations in the PEX genes, which code for peroxins that are required for peroxisomal biogenesis. Clinically, they are expressed as a Zellweger syndrome spectrum, and there is a wide phenotypic variety. They are diagnosed biochemically, and confirmation is molecular. Read More

View Article

Download full-text PDF

Source
October 2018
3 Reads

Yeast peroxisomes: How are they formed and how do they grow?

Int J Biochem Cell Biol 2018 Dec 27;105:24-34. Epub 2018 Sep 27.

Molecular Cell Biology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, the Netherlands. Electronic address:

Peroxisomes are single membrane enclosed cell organelles, which are present in almost all eukaryotic cells. In addition to the common peroxisomal pathways such as β-oxidation of fatty acids and decomposition of HO, these organelles fulfil a range of metabolic and non-metabolic functions. Peroxisomes are very important since various human disorders exist that are caused by a defect in peroxisome function. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13572725183021
Publisher Site
http://dx.doi.org/10.1016/j.biocel.2018.09.019DOI Listing
December 2018
22 Reads

Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia.

Hum Mol Genet 2019 Jan;28(1):143-154

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Glucose-6-phosphatase α (G6Pase) deficiency, also known as von Gierke's Disease or Glycogen storage disease type Ia (GSD Ia), is characterized by decreased ability of the liver to convert glucose-6-phosphate to glucose leading to glycogen accumulation and hepatosteatosis. Long-term complications of GSD Ia include hepatic adenomas and carcinomas, in association with the suppression of autophagy in the liver. The G6pc-/- mouse and canine models for GSD Ia were treated with the pan-peroxisomal proliferator-activated receptor agonist, bezafibrate, to determine the drug's effect on liver metabolism and function. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/hmg/advance-article/doi/10.1093/hmg
Publisher Site
http://dx.doi.org/10.1093/hmg/ddy343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298237PMC
January 2019
23 Reads

Pexophagy in yeast and mammals: an update on mysteries.

Histochem Cell Biol 2018 Nov 21;150(5):473-488. Epub 2018 Sep 21.

Institute of Molecular Health Sciences, ETH Zurich, Otto-Stern-Weg 7, HPL H16, 8093, Zurich, Switzerland.

Peroxisomes are ubiquitous and highly dynamic organelles that play a central role in the metabolism of lipids and reactive oxygen species. The importance of peroxisomal metabolism is illustrated by severe peroxisome biogenesis disorders in which functional peroxisomes are absent or disorders caused by single peroxisomal enzyme deficiencies. These multisystemic diseases manifest specific clinical and biochemical disturbances that originate from the affected peroxisomal pathways. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00418-018-1724-3
Publisher Site
http://dx.doi.org/10.1007/s00418-018-1724-3DOI Listing
November 2018
12 Reads

Expanding the concept of peroxisomal diseases and efficient diagnostic system in Japan.

J Hum Genet 2019 Feb 20;64(2):145-152. Epub 2018 Sep 20.

Division of Genomics Research, Life Science Research Center, Gifu University, Gifu, Japan.

The concept of peroxisomal diseases is expanding because of improvements in diagnostic technology based on advanced biochemical analysis and development of next-generation sequencing. For quicker and more accurate diagnosis of as many patients as possible, we developed a new diagnostic system combining the conventional diagnostic system and comprehensive mutational analysis by whole-exome sequencing in Japan. Adrenoleukodystrophy (ALD) is the most common peroxisomal disease. Read More

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s10038-018-0512-1
Publisher Site
http://dx.doi.org/10.1038/s10038-018-0512-1DOI Listing
February 2019
3 Reads

A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma.

Saudi J Ophthalmol 2018 Jul-Sep;32(3):241-245. Epub 2017 Sep 23.

King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.

Peroxisomal biogenesis disorders (PBDs) are autosomal recessive diseases caused by mutations in one of the 14 PEX genes described in the scientific literature. All of these syndromes may be associated with different mutations in the PEX genes, the most frequent being PEX1 for patients with Zellweger syndrome (ZS). In this paper, we present the case of a patient with a peculiar clinical history: evisceration of the left eye (LE) at 4 years of age because of a benign ocular teratoid medulloepithelioma and a progressive loss of visual acuity (VA) in the right eye (RE) beginning at 9 years of age, leading to the diagnosis of ZS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sjopt.2017.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137698PMC
September 2017

The peroxisome: an update on mysteries 2.0.

Histochem Cell Biol 2018 Nov 15;150(5):443-471. Epub 2018 Sep 15.

Biosciences, University of Exeter, Exeter, EX4 4QD, UK.

Peroxisomes are key metabolic organelles, which contribute to cellular lipid metabolism, e.g. the β-oxidation of fatty acids and the synthesis of myelin sheath lipids, as well as cellular redox balance. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00418-018-1722-5
Publisher Site
http://dx.doi.org/10.1007/s00418-018-1722-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182659PMC
November 2018
12 Reads

Hyper-IgD syndrome in a patient with IgA immunodeficiency.

Clin Exp Rheumatol 2018 Sep-Oct;36(5):934. Epub 2018 Jul 19.

Institute of Infection, Immunity and Inflammation, University of Glasgow, UK; and Rheumatology Department, Army Shared Fund "NIMTS" Hospital, Athens, Greece.

View Article

Download full-text PDF

Source
January 2019
5 Reads

Dysregulation of the NUDT7-PGAM1 axis is responsible for chondrocyte death during osteoarthritis pathogenesis.

Nat Commun 2018 08 24;9(1):3427. Epub 2018 Aug 24.

Department of Biological Sciences, College of Natural Sciences, Wonkwang University, Iksan, Chunbuk, 54538, Republic of Korea.

Osteoarthritis (OA) is the most common degenerative joint disease; however, its etiopathogenesis is not completely understood. Here we show a role for NUDT7 in OA pathogenesis. Knockdown of NUDT7 in normal human chondrocytes results in the disruption of lipid homeostasis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-05787-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109082PMC

Reconstitution of human peroxisomal β-oxidation in yeast.

FEMS Yeast Res 2018 12;18(8)

Department of Cell Biology, University of Alberta, Edmonton, MSB 5-14, Edmonton, Alberta T6G 2H7, Canada.

We report the permanent introduction of the human peroxisomal β-oxidation enzymatic machinery required for straight chain degradation of fatty acids into the yeast, Saccharomyces cerevisiae. Peroxisomal β-oxidation encompasses four sequential reactions that are confined to three enzymes. The genes encoding human acyl-CoA oxidase 1, peroxisomal multifunctional enzyme type 2 and 3-ketoacyl-CoA thiolase were introduced into the genomic loci of their yeast gene equivalents. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/femsyr/foy092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125039PMC
December 2018
9 Reads

Research, diagnosis and education in inborn errors of metabolism in Colombia: 20 years' experience from a reference center.

Orphanet J Rare Dis 2018 Aug 16;13(1):141. Epub 2018 Aug 16.

Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Cra. 7 No 43 - 82, Building 54, Room 305A, Bogotá, Colombia.

The use of specialized centers has been the main alternative for an appropriate diagnosis, management and follow up of patients affected by inborn errors of metabolism (IEM). These centers facilitate the training of different professionals, as well as the research at basic, translational and clinical levels. Nevertheless, few reports have described the experience of these centers and their local and/or global impact in the study of IEM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-018-0879-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097205PMC
August 2018
11 Reads

Expanding the spectrum of mutations and novel insights into disease mechanisms.

Mol Genet Metab Rep 2018 Sep 20;16:46-51. Epub 2018 Jul 20.

Department of Neurogenetics, Kolling Institute, Royal North Shore Hospital, St. Leonards, NSW, Australia.

Zellweger syndrome spectrum disorders are caused by mutations in any of at least 12 different genes. This includes , an important regulator of peroxisome biogenesis. Using whole genome sequencing, we detected previously unreported, biallelic variants in [NM_004813. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymgmr.2018.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072801PMC
September 2018
3 Reads

Clinical and Neuroimaging Spectrum of Peroxisomal Disorders.

Top Magn Reson Imaging 2018 Aug;27(4):241-257

Division of Pediatric Radiology and Pediatric Neuroradiology, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD.

Peroxisomes play vital roles in a broad spectrum of cellular metabolic pathways. Defects in genes encoding peroxisomal proteins can result in a wide array of disorders, depending upon the metabolic pathways affected. These disorders can be broadly classified into 2 main groups; peroxisome biogenesis disorders (PBDs) and single peroxisomal enzyme deficiencies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RMR.0000000000000172DOI Listing
August 2018
22 Reads

Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Ann Neurol 2018 Sep;84(3):452-462

Moser Center for Leukodystrophies, Kennedy Krieger Institute.

Objective: X-linked adrenoleukodystrophy (ALD) is a neurodegenerative disorder due to mutations in the peroxisomal very long-chain fatty acyl-CoA transporter, ABCD1, with limited therapeutic options. ALD may manifest in a slowly progressive adrenomyeloneuropathy (AMN) phenotype, or switch to rapid inflammatory demyelinating cerebral disease (cALD), in which microglia have been shown to play a pathophysiological role. The aim of this study was to determine the role of patient phenotype in the immune response of ex vivo monophagocytic cells to stimulation, and to evaluate the efficacy of polyamidoamine dendrimer conjugated to the antioxidant precursor N-acetyl-cysteine (NAC) in modulating this immune response. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.25303
Publisher Site
http://dx.doi.org/10.1002/ana.25303DOI Listing
September 2018
28 Reads
9.980 Impact Factor

[Biogenesis, the Function of Peroxisomes, and Their Role in Genetic Disease: With a Focus on the ABC Transporter].

Authors:
Tsuneo Imanaka

Yakugaku Zasshi 2018 ;138(8):1067-1083

Department of Biological Chemistry, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.

 Peroxisomes are organelles that are present in almost all eukaryotic cells. These organelles were first described in 1954, in the cytoplasm of the proximal tubule cells in the mouse kidney, using electron microscopy by Rhodin and referred to as "microbodies". Then, de Duve and Baudhuin isolated microbodies from rat liver using density gradient centrifugation, defined the microbodies as membrane-bound organelles containing several HO-producing oxidases and HO-degrading catalase, and named them peroxisomes. Read More

View Article

Download full-text PDF

Source
https://www.jstage.jst.go.jp/article/yakushi/138/8/138_18-00
Publisher Site
http://dx.doi.org/10.1248/yakushi.18-00023DOI Listing
August 2018
5 Reads

Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders.

Case Rep Gastroenterol 2018 May-Aug;12(2):360-372. Epub 2018 Jun 28.

Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.

Zellweger spectrum disorders (ZSDs), a subgroup of peroxisomal biogenesis disorders, have a generalized defect in peroxisome function. Liver disease in ZSDs has been linked to accumulation of C-bile acid intermediates due to the lack of peroxisomal β-oxidation of these intermediates to form primary C-bile acids. Oral treatment with primary bile acid, cholic acid (CA), inhibits formation of hepatotoxic C-bile acids by restoring normal physiologic feedback inhibition on bile acid synthesis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062720PMC
June 2018
3 Reads

Borago officinalis seed oil (BSO), a natural source of omega-6 fatty acids, attenuates fat accumulation by activating peroxisomal beta-oxidation both in C. elegans and in diet-induced obese rats.

Food Funct 2018 Aug;9(8):4340-4351

University of Navarra, School of Sciences, Department of Biochemistry and Genetics, Pamplona, Spain.

Obesity is a medical condition with increasing prevalence, characterized by an accumulation of excess fat that could be improved using some bioactive compounds. However, many of these compounds with in vitro activity fail to respond in vivo, probably due to the sophistication of the physiological energy regulatory networks. In this context, C. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8fo00423dDOI Listing
August 2018
4 Reads

Induction of peroxisomal changes in oligodendrocytes treated with 7-ketocholesterol: Attenuation by α-tocopherol.

Biochimie 2018 Oct 19;153:181-202. Epub 2018 Jul 19.

Univ. Bourgogne Franche-Comté, Lab. Bio-PeroxIL, 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism' (EA7270) / Inserm, Dijon, France. Electronic address:

The involvement of organelles in cell death is well established especially for endoplasmic reticulum, lysosomes and mitochondria. However, the role of the peroxisome is not well known, though peroxisomal dysfunction favors a rupture of redox equilibrium. To study the role of peroxisomes in cell death, 158 N murine oligodendrocytes were treated with 7-ketocholesterol (7 KC: 25-50 μM, 24 h). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2018.07.009DOI Listing
October 2018
8 Reads

PEX10-related autosomal recessive cerebellar ataxia with hearing loss.

Acta Neurol Belg 2018 Jul 19. Epub 2018 Jul 19.

Department of Pediatric Neurology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13760-018-0987-8DOI Listing

[A boy with treatment-resistant psychiatric problems: X-linked adrenoleukodystrophy].

Tijdschr Psychiatr 2018;60(7):485-489

In this case report we describe a 17-year-old boy with severe behavioural disorders, apathy and cognitive decline who was eventually diagnosed with X-linked adrenoleukodystrophy (x-ald). If a patient presents with a combination of psychiatric and neurological problems, metabolic diseases such as x-ald should be included in the differential diagnosis. Read More

View Article

Download full-text PDF

Source
February 2019
14 Reads

Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.

Clin Chim Acta 2018 Oct 7;485:305-310. Epub 2018 Jul 7.

Department of Neurology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, India.

Background: Elevated C26:0-lysophosphatidylcholine (LPC) is used as a biomarker to screen newborns for X-linked adrenoleukodystrophy (X-ALD), an inherited peroxisomal disorder. Our aim was to develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based assay for estimating a panel of LPCs (C20:0, C22:0, C24:0 and C26:0) from dried blood spots (DBS) and to evaluate its sensitivity and specificity for identification of X-ALD in clinically suspected cases.

Methods: LPCs (C20:0 - C26:0) were extracted from 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2018.07.007DOI Listing
October 2018

Novel ABCD1 Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum.

Neurodegener Dis 2018 2;18(2-3):156-164. Epub 2018 Jul 2.

Department of Neurology, Peking University People's Hospital, Beijing, China.

Background: Adult adrenomyeloneuropathy (AMN) is caused by mutations in the ABCD1 gene. Some pure AMN patients develop cerebral demyelination late in life. However, hypoplasia and agenesis of the corpus callosum (CC) has never been reported in AMN patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000490248DOI Listing
January 2019
7 Reads

Peroxisome-targeted Supramolecular Nanoprobes Assembled with Pyrene-labelled Peptide Amphiphiles.

Chem Asian J 2018 Nov 7;13(22):3485-3490. Epub 2018 Aug 7.

School of Materials Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.

Despite the versatile metabolic functions of peroxisomes such as lipid synthesis and fatty acid oxidation and their relevance to genetically inherited diseases, namely, peroxisome biogenesis disorders and peroxisomal enzyme deficiency, there is not much research on peroxisome-targeting therapeutics. Herein we present supramolecular nanostructured probes based on the self-assembly of peptide amphiphiles (PAs) having peroxisome-targeting ability in mammalian cells. The PA was designed to include the peroxisome-targeting tripeptide (SKL) and a fluorescent dye (pyrene). Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/asia.201800863
Publisher Site
http://dx.doi.org/10.1002/asia.201800863DOI Listing
November 2018
4 Reads

Dietary rescue of lipotoxicity-induced mitochondrial damage in Peroxin19 mutants.

PLoS Biol 2018 Jun 19;16(6):e2004893. Epub 2018 Jun 19.

University of Bonn, Life & Medical Sciences Institute (LIMES), Molecular Developmental Biology, Bonn, Germany.

Mutations in peroxin (PEX) genes lead to loss of peroxisomes, resulting in the formation of peroxisomal biogenesis disorders (PBDs) and early lethality. Studying PBDs and their animal models has greatly contributed to our current knowledge about peroxisomal functions. Very-long-chain fatty acid (VLCFA) accumulation has long been suggested as a major disease-mediating factor, although the exact pathological consequences are unclear. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pbio.2004893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025876PMC
June 2018
10 Reads

Neuronal Dysfunction and Behavioral Abnormalities Are Evoked by Neural Cells and Aggravated by Inflammatory Microglia in Peroxisomal β-Oxidation Deficiency.

Front Cell Neurosci 2018 23;12:136. Epub 2018 May 23.

Laboratory for Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven-University of Leuven, Leuven, Belgium.

It is becoming evident that microglia, the resident immune cells of the central nervous system (CNS), are active contributors in neurological disorders. Nevertheless, the impact of microgliosis on neuropathology, behavior and clinical decline in neuropathological conditions remains elusive. A mouse model lacking multifunctional protein-2 (MFP2), a pivotal enzyme in peroxisomal β-oxidation, develops a fatal disorder characterized by motor problems similar to the milder form of human disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fncel.2018.00136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975114PMC
May 2018
26 Reads

[Bicentennial of catalase research, 1818-2018].

Authors:
László Góth

Orv Hetil 2018 Jun;159(24):959-964

Orvosi Laboratóriumi és Képalkotó Diagnosztikai Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen, Nagyerdei krt. 98., 4012.

L. J. Thénard and J. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1556/650.2018.31096DOI Listing

Intracellular organelles in health and kidney disease.

Nephrol Ther 2018 Jun 7. Epub 2018 Jun 7.

Faculty of medicine (poursina), division of nephrology, Imam-Khomeini hospital, National Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Subcellular organelles consist of smaller substructures called supramolecular assemblies and these in turn consist of macromolecules. Various subcellular organelles have critical functions that consist of genetic disorders of organelle biogenesis and several metabolic disturbances that occur during non-genetic diseases e.g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nephro.2018.04.002DOI Listing
June 2018
6 Reads

A novel mutation in the ABCD1 gene of a Chinese patient with X-linked adrenoleukodystrophy: Case report.

Medicine (Baltimore) 2018 May;97(21):e10837

Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu.

Rationale: X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder, which is inherited as an X-linked recessive trait. ATP binding cassette subfamily D member 1 (ABCD1) localized to Xq28 is the only gene associated with ALD.

Patient Concerns: We report a case of Chinese boy with childhood cerebral ALD, who began experiencing symptoms at the age of 5 years and 2 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010837DOI Listing
May 2018
6 Reads

Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.

J Mol Med (Berl) 2018 Jul 18;96(7):621-630. Epub 2018 May 18.

Division of Pediatric Nephrology, Shaare Zedek Medical Center, Shmuel Bait Street, 91031, Jerusalem, Israel.

Primary hyperoxaluria type 1 is a severe kidney stone disease caused by abnormalities of the peroxisomal alanine-glyoxylate aminotransferase (AGT). The most frequent mutation G170R results in aberrant mitochondrial localization of the active enzyme. To evaluate the population of peroxisome-localized AGT, we developed a quantitative Glow-AGT assay based on the self-assembly split-GFP approach and used it to identify drugs that can correct mislocalization of the mutant protein. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-018-1651-8DOI Listing
July 2018
22 Reads
5.110 Impact Factor

Super-resolution imaging reveals the sub-diffraction phenotype of Zellweger Syndrome ghosts and wild-type peroxisomes.

Sci Rep 2018 May 17;8(1):7809. Epub 2018 May 17.

Department of Pediatrics and Adolescent Medicine, University Medical Center Göttingen, Georg August University Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.

Peroxisomes are ubiquitous cell organelles involved in many metabolic and signaling functions. Their assembly requires peroxins, encoded by PEX genes. Mutations in PEX genes are the cause of Zellweger Syndrome spectrum (ZSS), a heterogeneous group of peroxisomal biogenesis disorders (PBD). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-24119-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958128PMC
May 2018
1 Read

Spastic paraparesis caused by X-linked adrenoleukodystrophy mimicking vacuolar myelopathy in a human immunodeficiency virus patient: A case report.

Medicine (Baltimore) 2018 May;97(20):e10756

Department of Rehabilitation Medicine, Daegu Fatima Hospital.

Rationale: Vacuolar myelopathy is one of most common cause of spastic paresis in patients with human immunodeficiency virus (HIV) infection. However, X-linked adrenoleukodystrophy (X-ALD), which is a metabolic disorder caused by impairment of peroxisomal beta-oxidation of very-long-chain fatty acids (VLCFA), also manifests as various neurological deteriorations including adult onset spastic paraparesis. To the best of our knowledge, there has been no report of newly developed spastic paresis due to X-ALD in a patient with HIV infection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976296PMC
May 2018
3 Reads

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

N Engl J Med 2018 05;378(20):1908-1919

From the Division of Rheumatology, Ospedale Pediatrico Bambino Gesù, Rome (F.D.B.), Clinica Pediatrica e Reumatologia, Unità Operativa Semplice Dipartimentale di Malattie Autoinfiammatorie e Immunodeficienze, IRCCS, Istituto G. Gaslini, Genoa (M.G.), the Pediatric Clinic, University of Brescia and Spedali Civili, Brescia (M.C.), and the Amyloidosis Research and Treatment Center, Biotechnology Research Laboratories, Fondazione IRCCS Policlinico San Matteo, Pavia (L.O.) - all in Italy; the Division of Pediatric Rheumatology, Hospital Sant Joan de Déu, Universitat de Barcelona (J.A.), and the Internal Medicine Department, Autoimmune and Systemic Diseases Unit, Hospital Vall d'Hebron (S.B.-R.), Barcelona, and the Pediatric Rheumatology Unit, Hospital Universitario y Politécnico La Fe, Valencia (I.C.P.) - all in Spain; the Rheumatology Unit, Hadassah-Hebrew University Hospital (E.B.-C.), and the Pediatric Rheumatology Unit, Shaare Zedek Medical Center (P.J.H.), Jerusalem, and Heller Institute of Medical Research and Medicine Faculty, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (A.L.) - all in Israel; the Division of Pediatrics, University Medical Center Utrecht, Utrecht (J.F.), and the Radboud Expertise Center for Immunodeficiency and Autoinflammation, Department of Internal Medicine, Radboud University Medical Center, Nijmegen (A. Simon) - both in the Netherlands; the Departments of Pediatrics and Medicine, University of California at San Diego and Rady Children's Hospital San Diego, San Diego (H.M.H.); the Department of Pediatric Rheumatology, Centre de Référence des Maladies Auto-inflammatoires et de l'Amylose Inflammatoire, Centre Hospitalier Universitaire (CHU) de Bicêtre, Assistance Publique-Hopitaux de Paris (APHP), Université de Paris Sud (I.K.-P.), and Paris-Descartes University, Imagine Institute, Unité d'Immuno-Hématologie et Rhumatologie Pédiatrique, Hôpital Necker-Enfants Malades, APHP (P.Q.), Paris; the National Amyloidosis Centre, University College London Division of Medicine, Royal Free Campus (H.J.L.), and University College London, Great Ormond Street Institute of Child Health, and Great Ormond Street Hospital for Children NHS Foundation Trust (P.B.), London; the Department of Pediatrics, Hacettepe University, Ankara (S.O.), and the Department of Pediatric Rheumatology, Cerrahpasa Medical School (O.K.), and Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology (A.G.), Istanbul University, Istanbul - all in Turkey; the Department of Pediatrics, Division of Pediatric Rheumatology, Cleveland Clinic, Cleveland (A.Z.); the Department of Infectious Diseases and General Internal Medicine, CHU Sart-Tilman, University of Liège, Liege (M.M.), and the Department of Infectious Diseases and Immunity, Jessa Hospital, University of Hasselt, Hasselt (J.V.H.) - both in Belgium; the Department of Clinical Immunology, Center for Pediatric Hematology, Oncology, and Immunology, Moscow (A. Shcherbina); Pediatric Rheumatology of Western Switzerland, University of Lausanne, Lausanne, (M.H.), and Novartis, Basel (K.L., A. Speziale, G.J.) - both in Switzerland; the Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Japan (R.H.); and the Department of Pediatrics, Semmelweis Egyetem, Budapest, Hungary (T.C.).

Background: Familial Mediterranean fever, mevalonate kinase deficiency (also known as the hyperimmunoglobulinemia D syndrome), and the tumor necrosis factor receptor-associated periodic syndrome (TRAPS) are monogenic autoinflammatory diseases characterized by recurrent fever flares.

Methods: We randomly assigned patients with genetically confirmed colchicine-resistant familial Mediterranean fever, mevalonate kinase deficiency, or TRAPS at the time of a flare to receive 150 mg of canakinumab subcutaneously or placebo every 4 weeks. Patients who did not have a resolution of their flare received an add-on injection of 150 mg of canakinumab. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706314DOI Listing
May 2018
13 Reads